News
One popular health platforms is promoting GLP-1 microdosing for weight loss: But how safe and effective is this approach?
As lawyers who represent whistleblowers under the False Claims Act, we expect a new era of fraud cases tied to GLP-1 drugs, ...
7h
The Kenya Times on MSNOzempic and Other Weight-loss Drugs Linked to Rare But Serious Eye ConditionsDrugs such as Ozempic, Wegovy and Mounjaro (known as semaglutide and tirzepatide) have changed the way clinicians manage ...
Christina Aguilera has been battling Ozempic allegations for years despite crediting her toned shape to diet and exercise.
10h
Inquisitr on MSNSerena Williams Accused of ‘Trying to Be White’ as Recent Weight Loss Transformation Sparks Mixed ReactionsFans are accusing Serena Williams of bleaching her skin, trying to be white and losing her black girl magic and healthy weight. She posted photos in which he appeared quite thinner than her usual self ...
Pin-thin pop star Christina Aguilera 's shockingly skeletal figure during a recent appearance in England has startled friends and fans – and further fed rumors that the once-plump performer may have ...
SALT LAKE CITY — It was a first-of-its-kind study conducted at the University of Utah on a drug that has, to date, changed ...
Novo Nordisk A/S (NYSE:NVO) is among the. Novo Nordisk A/S (NYSE:NVO) lowered its operating profit growth projections to ...
Researchers see good in the popular weight-loss drug, but hope their findings lead to more study on how it could cause muscle ...
Novo Nordisk's FY 2025 guidance cuts are driven by softer U.S. Wegovy/Ozempic and GLP-1 trends. Click here to find out why I ...
Novo Nordisk A/S is suffering from headwinds in its core anti-obesity medications market. Click here to find out why NVO ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results